Colossal, values the Dallas-based startup at a staggering $10.2 billion. Besides making it the first startup founded in Texas to be valued at eleven figures, the new funding round will bolster ...

"We’re in very different place," the CEO of Editas says, citing the CRISPR pioneer's plans to get its first treatments into ...

Colossal Biosciences, the world’s first company dedicated to bringing back animals from extinction, has secured $200 million ...

Colossal Biosciences announced Wednesday it had reached a $10 billion valuation, putting it in rare “unicorn” territory among Texas startups. The Dallas-based genetic engineering startup landed $200 ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

In Episode 746 of Power Athlete Radio, Dr. Adeel Khan dives into cutting-edge advancements in regenerative medicine, focusing on induced pluripotent stem cells ...

Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...

UK ministers are pressing ahead with legislation to adopt gene editing technology despite warnings from Brussels that it ...